Microsurgery Market Research Report - Global Forecast till 2030

Microsurgery Market Research Report Information By Solution (Web Content Management, Mobile Content Management, Documentation Management, Records Management and Content Workflow Management), By Service (Integration, Support & Maintenance and Training), By Deployment (On-Premises and Cloud), By Organization Size (SMEs and Large Enterprises), By Vertical (BFSI, Healthcare, Retail, IT & Telecommunication, Energy & Utilities and Transportation & Logistics), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) - Forecast Ti

ID: MRFR/MED/2870-CR | 161 Pages | Published By Kinjoll Dey on July 2019         

Microsurgery Market Speak to Analyst Request a Free Sample

Global Microsurgery Market Overview

Global Microsurgery Market Size was valued at USD 1.1 billion in 2021 and is projected to grow from USD 1.2 billion in 2022 to USD 1.9 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.10% during the forecast period (2022 - 2030). The key market drivers responsible for the market's expansion are the rising number of surgical procedures, which are fueled by the aging population, rising incidence of lifestyle diseases, and better access to healthcare in developing nations.
Microsurgery Market Overview
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Microsurgery Market Trends

  • Advancements in microsurgical techniques and rapid technological advancement to drive the market growth

Due to technology advancements and advances, such as optical devices and surgical tools, microsurgery has significantly contributed to surgical therapy. The most recent and updated knowledge in a wide range of medical specialities, including immunotherapy and pharmacology, has thus been made available by microsurgical procedures. The International Society for Experimental Microsurgery (ISEM), a professional association of academics, has used experimental microsurgery technology to find therapeutic remedies for illnesses that have proven difficult to treat. For instance, a novel method of ophthalmological surgery known as "heads-up surgery" has just been developed, in which the field of vision is displayed on a screen via a high-resolution camera. Currently, this method is being used in a number of microsurgeries with lengthy operating times that formerly required the use of a magnifying glass. A variety of operations employ heads-up surgery. Furthermore, heads-up surgery employing a three-dimensional (3D) video camera could be advantageous for a number of microsurgeries. The market revenue growth is anticipated to be driven by the availability of high-performance Charge-Coupled Device (CCD) cameras and imaging techniques, which are offering additional alternatives for enhanced microsurgical techniques. Thus, this factor is driving the market CAGR.

However, market expansion is anticipated to be fueled by the rising incidence of conditions including breast cancer, Barrett's oesophagus, melanoma and non-melanoma skin cancer, prostate cancer, and other illnesses. Furthermore, the World Health Organization (WHO) estimates that 2 to 3 million non-melanoma skin cancers and 132,000 melanoma skin cancers ly are diagnosed each year. Because of this, the worldwide microsurgery sector will experience more significant market expansion due to the rising demand for microsurgery in both developed and emerging nations. With each additional chronic ailment that requires more access to specialized physicians, presentations at emergency rooms, and hospital stays, healthcare costs rise significantly, sometimes dramatically. The patient burden encompasses declining quality of life, out-of-pocket costs, adherence to medications, incapacity to work, symptom control, and a significant financial cost to careers. It is also anticipated that the significant burden imposed by MCCs will fuel market expansion.

In addition to cosmetic plastic surgery, microsurgery is widely used. Several more serious conditions are being treated with it. This is particularly accurate given the rising frequency of skin cancers, including melanoma, non-melanoma, and breast cancer. Barrette's oesophagus and prostate cancer are two other conditions that necessitate microsurgery. The cosmetic surgery trend is attracting a lot of people in both developed and developing countries. The desire is mostly motivated by more purchasing power and a desire to feel and appear young. The desire to resemble favored celebrities is widespread. The desire to mimic their distinctive facial traits is also present. The need for microsurgery worldwide is being driven by this. Thus, it is anticipated that this aspect will accelerate microsurgery market revenue ly.

Microsurgery Market Segment Insights

Microsurgery Procedure Insights

The microsurgery market segmentation has been segmented by procedure into Transplantation, Replantation, Free Flap Tissue Transfer and Vascular Anastomoses. The transplantation segment dominated the market growth in 2021 and is projected to be the faster-growing segment during the forecast period, 2022-2030 because there are more transplantation centers worldwide and more organ transplant procedures being performed. Around 34,768 organ transplants were carried out in the United States in 2020, according to United Network for Organ Sharing (UNOS). Additionally, according to UNOS, someone is added to the national transplant waiting list every 10 minutes, and on average, 22 people pass away each day while on the transplant waiting list.

Microsurgery Application Insights

The microsurgery market segmentation, based on application, General Surgery, Neurosurgery, Ophthalmology, Reconstructive & Plastic Surgery and Oncology. The oncology segment dominated the microsurgery market revenue in 2021 and is projected to be the faster-growing segment during the forecast period, 2022-2030 because cancer is becoming more common and there are more cancer operations. The National Cancer Institute estimates that in 2020 there will be 1,806,590 new cancer cases identified and 606,520 cancer-related deaths in the United States. Additionally, according to the World Health Organization (WHO), 9.6 million cancer deaths and 18.1 million new cancer cases were reported ly in 2018.

Microsurgery Equipment Insights

The microsurgery market data, based on equipment, Microsurgical Instruments, Microscope and Suture Materials. The microscope segment dominated the microsurgery market revenue in 2021 and is projected to be the faster-growing segment during the forecast period, 2022-2030. Operating microscopes are being used more and more in operating rooms because they offer great view of the surgical field, high illumination, and adjustable magnification. These microscopes also enable medical personnel to carry out intricate treatments and enhance surgical results during ophthalmic, plastic, and reconstructive surgeries as well as neurosurgeries.

Figure 2:  Microsurgery Market by Equipment, 2021 & 2030 (USD Billion)
Microsurgery Market by Equipment, 2021 & 2030
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Microsurgery End User Insights

Based on end user, the  microsurgery industry, is segmented into Hospitals & Clinics, Ambulatory Surgical Centers and Research Organizations. The hospitals & clinics segment dominated the market in 2021 and is projected to be the faster-growing segment during the forecast period, 2022-2030 because hospitals do a substantial number of organ transplant surgeries. The American Hospital Association (AHA) estimates that there were around 5,534 community hospitals in the United States in 2019.

Microsurgery Regional Insights

By region, the study provides the market insights into North America, Europe, Asia-Pacific, and the Rest of the World. North America microsurgery market accounted for USD 0.5 billion in 2021 and is expected to exhibit a 44.30% CAGR during the study period. This is explained by the growing elderly population in the area. The fact that more people in this region are dealing with conditions like various forms of arthritis and cataracts is helping the local market flourish.

Further, the major countries studied in the market report are: The U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Asia Pacific microsurgery market accounts for the fastest growing market share because of rising medical tourism and supportive government programmes for the development of innovative healthcare service delivery systems & infrastructure. Moreover, China microsurgery market held the largest market share, and the India microsurgery market was the fastest-growing market in this region.

Europe microsurgery market is expected to grow at a substantial CAGR from 2022 to 2030. The market for microsurgery is driven by the availability of funding for research and development, rising public awareness of available therapies, and a well-developed healthcare system. Further, the UK microsurgery market held the largest market share, and the Germany microsurgery market was the fastest-growing market in the region.

Microsurgery Key Market Players & Competitive Insights

Major market players are spending a lot on R&D to increase their product lines, which will help the microsurgery industry grow even more. Market participants are also taking various strategic initiatives to grow their worldwide footprint, including new product launches, contractual agreements, mergers and acquisitions, increased investments, market developments and collaboration with other organizations. Competitors in the industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market industry.

One of the primary business strategies manufacturers adopt in the  microsurgery industry to benefit clients and expand the sector is manufacturing locally to reduce operating costs. In recent years, microsurgery industry has provided medicine with some of the most significant benefits. The microsurgery market major player such as S&T AG (Austria), Synovis Micro Companies AllianceInc (USA), Stryker Corporation (USA), Ethicon Inc (USA), Novartis (Sweden), Smith and Nephew (USA), Zimmer Biomet Holdings (USA), Medtronic PLC (USA), Carl Zeiss Meditech AG (Germany), Peter Lazic GmBH (Germany) and Microsurgery Instruments.

American medical technology company Stryker Corporation is headquartered in Kalamazoo, Michigan. Surgical instruments, surgical navigation systems, endoscopic and communications systems, as well as other medical device goods utilised in a number of medical specialties, are just a few of the products produced by Stryker. In October 2020, ProCuity, the first and only fully wireless hospital bed in the market, was launched ly by Stryker. This intelligent bed was created to decrease in-hospital patient falls across the board, increase nurse safety and workflow efficiency, and contribute to lower hospital expenses.

Also, Carl Zeiss created Carl Zeiss AG, often known as ZEISS, an optical and optoelectronics business in Jena, Germany, in 1846. He helped lay the groundwork for the current multinational corporation with Otto Schott and Ernst Abbe. In October 2018, ReLEx Smile, created by Carl Zeiss Meditec AG, has received FDA approval for use in patients undergoing refractive surgery.

Key companies in the microsurgery market includes

  • S&T AG - Austria

  • Synovis Micro Companies AllianceInc- USA

  • Stryker Corporation - USA

  • Ethicon Inc - USA

  • Novartis - Sweden

  • Smith and Nephew - USA

  • Zimmer Biomet Holdings - USA

  • Medtronic PLC - USA

  • Carl Zeiss Meditech AG - Germany

  • Peter Lazic GmBH - Germany

  • Microsurgery Instruments

Microsurgery Industry Developments

September 2022: New Supermicro NanoWrist instruments have been introduced by Medical Microinstruments Inc. (MMI) for use with the Symani Surgical System. The tools have been created especially to handle the difficulties of microsurgery. A recent clinical procedure in Zürich, Florence, and Salzburg used the new supermicro needle holder and dilator, and the results for the patients were positive.

April 2021: Maxer Endoscopy will be purchased by German company Erbe Elektromedizin, which manufactures surgical instruments and equipment. With the help of 4K and fluorescence-guided devices, Erbe Elektromedizin anticipates improving performance during endoscopic and surgical procedures as well as growing its surgical endoscopy business as a result of this acquisition.

Microsurgery Market Segmentation

Microsurgery Procedure Outlook (USD Billion, 2018-2030)

  • Transplantation

  • Replantation

  • Free Flap Tissue Transfer

  • Vascular Anastomoses

Microsurgery Application Outlook (USD Billion, 2018-2030)

  • General Surgery

  • Neurosurgery

  • Ophthalmology

  • Reconstructive & Plastic Surgery

  • Oncology

Microsurgery Equipment Outlook (USD Billion, 2018-2030)

  • Microsurgical Instruments

  • Microscope

  • Suture Materials

Microsurgery End User Outlook (USD Billion, 2018-2030)

  • Hospitals & Clinics

  • Ambulatory Surgical Centers

  • Research Organizations

Microsurgery Regional Outlook (USD Billion, 2018-2030)

  • North America

    • US

    • Canada

  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe

    • Asia-Pacific

  • China

    • Japan

    • India

    • Australia

    • South Korea

    • Australia

    • Rest of Asia-Pacific

  • Rest of the World

    • Middle East

    • Africa

    • Latin America

Report Scope:

Report Attribute/Metric Details
Market Size 2021 USD 1.1 Billion
Market Size 2022 USD 1.2 Billion
Market Size 2030 USD 1.9 Billion
Compound Annual Growth Rate (CAGR) 7.10% (2022-2030)
Base Year 2021
Forecast Period 2022-2030
Historical Data 2018 & 2020
Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered Procedure, Application, Equipment, End User and Region
Geographies Covered North America, Europe, Asia Pacific, and Rest of the World
Countries Covered The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
Key Companies Profiled S&T AG (Austria), Synovis Micro Companies AllianceInc (USA), Stryker Corporation (USA), Ethicon Inc (USA), Novartis (Sweden), Smith and Nephew (USA), Zimmer Biomet Holdings (USA)
Key Market Opportunities Increasing demand for cosmetic surgeries
Key Market Dynamics Rising prevalence of chronic diseases Advancements in microsurgical techniques and rapid technological advancement to drive market

Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

The market size was expected to be USD 1.1 billion in 2021.

The market is expected to register a CAGR of ~7.10% over the next ten years.

North America held the largest market share in the market.

S&T AG (Austria), Synovis Micro Companies AllianceInc (USA), Stryker Corporation (USA), Ethicon Inc (USA), Novartis (Sweden), Smith and Nephew (USA), Zimmer Biomet Holdings (USA) are the key players in the market.

The transplantation category led the segment in the market.

The hospitals & clinics category had the largest market share in the market.